Pancreatic Cancer Research

ResearcherUniversity of MichiganActive in the last 2 years

Elena M. Stoffel

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-5637-3418; OpenAlex author ID A5038045975. Sources: ClinicalTrials.gov.

Their work

Papers
18 (first author 1, last author 0)
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
121
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: 1 paper · 2019: 4 papers · 2020: 2 papers · 2021: 2 papers · 2022: 3 papers, 1 trial · 2023: 2 papers · 2024: 3 papers

Papers 18

  1. Pancreatic Cancer Surveillance and Survival of High-Risk Individuals. Co-author DOI 10.1001/jamaoncol.2024.1930↗
  2. Genetic and other risk factors for pancreatic ductal adenocarcinoma (PDAC). First author DOI 10.1007/s10689-024-00372-5↗
  3. The Pancreatic Cancer Early Detection (PRECEDE) Study is a Global Effort to Drive Early Detection: Baseline Imaging Findings in High-Risk Individuals. Co-author DOI 10.6004/jnccn.2023.7097↗
  4. Pancreatic Cancer: Changing Epidemiology and New Approaches to Risk Assessment, Early Detection, and Prevention. Co-author DOI 10.1053/j.gastro.2023.02.012↗
  5. Racial, Ethnic, and Sex-based Disparities among High-risk Individuals Undergoing Pancreatic Cancer Surveillance. Co-author DOI 10.1158/1940-6207.capr-22-0529↗
  6. ASGE guideline on screening for pancreatic cancer in individuals with genetic susceptibility: summary and recommendations Co-author DOI 10.1016/j.gie.2021.12.001↗
  7. American Society for Gastrointestinal Endoscopy guideline on screening for pancreatic cancer in individuals with genetic susceptibility: methodology and review… Co-author DOI 10.1016/j.gie.2021.12.002↗
  8. Timeline of Development of Pancreatic Cancer and Implications for Successful Early Detection in High-Risk Individuals. Co-author DOI 10.1053/j.gastro.2021.10.014↗
  9. COVID-19 related pancreatic cancer surveillance disruptions amongst high-risk individuals. Co-author DOI 10.1016/j.pan.2021.04.005↗
  10. Screening for Pancreatic Ductal Adenocarcinoma: Are We Asking the Impossible?—Letter Co-author DOI 10.1158/1940-6207.capr-21-0233↗
  11. Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAP… Co-author DOI 10.1136/gutjnl-2019-319352↗
  12. Correction: Management of patients with increased risk for familial pancreatic cancer: updated recommendations for the international cancer of the pancreas scr… Co-author DOI 10.1136/gutjnl-2019-319352corr1↗
  13. Surveillance for pancreatic cancer in high-risk individuals. Co-author DOI 10.1002/bjs5.50180↗
  14. Evaluating Susceptibility to Pancreatic Cancer: ASCO Provisional Clinical Opinion. Co-author DOI 10.1200/jco.18.01489↗
  15. Evaluating Susceptibility to Pancreatic Cancer: ASCO Clinical Practice Provisional Clinical Opinion Summary. Co-author DOI 10.1200/jop.18.00629↗
  16. A region-based gene association study combined with a leave-one-out sensitivity analysis identifies SMG1 as a pancreatic cancer susceptibility gene. Co-author DOI 10.1371/journal.pgen.1008344↗
  17. Mutations in the pancreatic secretory enzymes CPA1 and CPB1 are associated with pancreatic cancer. Co-author DOI 10.1073/pnas.1720588115↗
  18. Whole Genome Sequencing Defines the Genetic Heterogeneity of Familial Pancreatic Cancer. Co-author DOI 10.1158/2159-8290.cd-15-0402↗

Trials 1

  1. Michigan Genetic Hereditary Testing (MiGHT) Principal investigator NCT05162846↗

Closest collaborators

The 25 strongest of 121 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Randall E. Brand · 14 shared papers, 2016–2024 · strength 1.54
  2. Michael Goggins · 11 shared papers, 2016–2024 · strength 1.21
  3. Marcia Irene Canto · 11 shared papers, 2018–2024 · strength 1.11
  4. Fay Kastrinos · 9 shared papers, 2019–2024 · strength 0.98
  5. Sapna Syngal · 10 shared papers, 2016–2024 · strength 0.89
  6. James J. Farrell · 6 shared papers, 2020–2024 · strength 0.73
  7. Bryson W. Katona · 5 shared papers, 2021–2024 · strength 0.65
  8. Aimee Lee Lucas · 6 shared papers, 2019–2024 · strength 0.59
  9. Diane M. Simeone · 5 shared papers, 2019–2024 · strength 0.50
  10. Ralph H. Hruban · 6 shared papers, 2016–2024 · strength 0.48
  11. Michelle F. Jacobs · 1 shared paper, 2024 · strength 0.46
  12. Anil K. Rustgi · 5 shared papers, 2016–2024 · strength 0.43
  13. Salvatore Paiella · 4 shared papers, 2019–2024 · strength 0.43
  14. George Zogopoulos · 5 shared papers, 2016–2024 · strength 0.41
  15. Alison P. Klein · 5 shared papers, 2016–2024 · strength 0.40
  16. Talia Golan · 3 shared papers, 2022–2024 · strength 0.37
  17. Julie Earl · 3 shared papers, 2022–2024 · strength 0.36
  18. Nirav C Thosani · 3 shared papers, 2022 · strength 0.34
  19. Jeanin Elise van Hooft · 4 shared papers, 2019–2022 · strength 0.33
  20. Marco J. Bruno · 4 shared papers, 2019–2022 · strength 0.33
  21. Anne Marie Lennon · 3 shared papers, 2020–2024 · strength 0.32
  22. Elliot K. Fishman · 3 shared papers, 2020–2024 · strength 0.32
  23. Steve Gallinger · 4 shared papers, 2016–2023 · strength 0.28
  24. Kasper A. Overbeek · 3 shared papers, 2020–2022 · strength 0.26
  25. Detlef Klaus Bartsch · 3 shared papers, 2020–2022 · strength 0.26

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.